Correlation Between GlaxoSmithKline PLC and Ecomiam SA
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Ecomiam SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Ecomiam SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Ecomiam SA, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Ecomiam SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Ecomiam SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Ecomiam SA.
Diversification Opportunities for GlaxoSmithKline PLC and Ecomiam SA
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between GlaxoSmithKline and Ecomiam is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Ecomiam SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ecomiam SA and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Ecomiam SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ecomiam SA has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Ecomiam SA go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Ecomiam SA
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Ecomiam SA. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 1.83 times less risky than Ecomiam SA. The stock trades about -0.23 of its potential returns per unit of risk. The Ecomiam SA is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest 273.00 in Ecomiam SA on August 31, 2024 and sell it today you would lose (40.00) from holding Ecomiam SA or give up 14.65% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 98.44% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Ecomiam SA
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Ecomiam SA |
GlaxoSmithKline PLC and Ecomiam SA Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Ecomiam SA
The main advantage of trading using opposite GlaxoSmithKline PLC and Ecomiam SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Ecomiam SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ecomiam SA will offset losses from the drop in Ecomiam SA's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Ecomiam SA vs. Verimatrix | Ecomiam SA vs. Agripower France Sa | Ecomiam SA vs. Nacon Sa | Ecomiam SA vs. Paulic Meunerie Sa |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |